![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_0b1e406a221d2c8c7961dd461e08e86f.svg) | Salmeterol | IC50 | 5.01 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_8da77bd1f8802d0742140cb4ceb0b7da.svg) | 1-[(7-Methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)-2-butanol | IC50 | 0.49 [1], 0.74 [2], 1.2 [3], 2.3 [4], 2.5 [5] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_8da77bd1f8802d0742140cb4ceb0b7da.svg) | 1-[(7-Methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)-2-butanol | Ki | 0.13 [1], 1.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_c70f5b79af37726016ec15cea0b55e94.svg) | Propranolol | IC50 | 50.12 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_c70f5b79af37726016ec15cea0b55e94.svg) | Propranolol | Ki | 0.46 [1], 0.77 [2], 1.74 [3], 3.69 [4] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_0f316e08160d2999e6ea804928aa42e0.svg) | Isoprenaline | Ki | 2.44 [1], 46.0 [2], 169.0 [3], 192.0 [4], 676.08 [5] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2f6aa077265088f9306897fbb768392e.svg) | Salbutamol | IC50 | 1995.26 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2f6aa077265088f9306897fbb768392e.svg) | Salbutamol | Ki | 510.0 [1], 557.0 [2], 1828.0 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_72456aaaa543e799097de36c30caec7a.svg) | 2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_72456aaaa543e799097de36c30caec7a.svg) | 2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid | Ki | 630.0 [1], 2850.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_6e72de4757e3ab390cf96a03823d9c18.svg) | R,R-Fenoterol | IC50 | 0.14 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_6e72de4757e3ab390cf96a03823d9c18.svg) | R,R-Fenoterol | Ki | 4.0 [1], 345.0 [2], 346.74 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_939c35d851337b3ca6a83f4165d68c0e.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 0.17 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_939c35d851337b3ca6a83f4165d68c0e.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 4.09 [1], 474.0 [2], 478.63 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_ab1e3be6b8181c57f392395ec6c21451.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 2.01 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_ab1e3be6b8181c57f392395ec6c21451.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 26.1 [1], 1930.0 [2], 1949.84 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_710d960405b331aadaf1b48e23eb18d9.svg) | (S,R)-(+)-Fenoterol | IC50 | 6.74 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_710d960405b331aadaf1b48e23eb18d9.svg) | (S,R)-(+)-Fenoterol | Ki | 1828.1 [1], 10232.93 [2], 10330.0 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_7c5b5ee1e7f85eb0e5f583fc7213ce89.svg) | (R,S)-(-)-Fenoterol | IC50 | 6.09 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_7c5b5ee1e7f85eb0e5f583fc7213ce89.svg) | (R,S)-(-)-Fenoterol | Ki | 183.0 [1], 3695.0 [2], 3715.35 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_74208b7f9b1ebcc57716409699997049.svg) | (S,S)-(+)-Fenoterol | IC50 | 184.2 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_74208b7f9b1ebcc57716409699997049.svg) | (S,S)-(+)-Fenoterol | Ki | 3372.87 [1], 27542.29 [2], 27749.0 [3] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_401e7d8739619d44f5d212db396141d1.svg) | Indacaterol | Ki | 20.6 [1], 76.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_5ecfabed9d7ba5abe95feae80d831bd0.svg) | 1-[(3,4,5-Trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | IC50 | 6.1 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_5ecfabed9d7ba5abe95feae80d831bd0.svg) | 1-[(3,4,5-Trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | Ki | 43.65 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_77389a2801f3f65ad7dd698c44ce344c.svg) | CID 9829836 | IC50 | 190.0 [1], 3000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_77389a2801f3f65ad7dd698c44ce344c.svg) | CID 9829836 | Ki | 160.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9182e75261c4c9a90083bb44381e7fec.svg) | L-796568 Free base | IC50 | 670.0 [1], 2300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_99f04051f3a3c2e2d86079a90b1965c9.svg) | 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]acetamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_dfc843e8fe38a894029d4b7914f61118.svg) | 5-[(1S)-1-Hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 3.16 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_dfc843e8fe38a894029d4b7914f61118.svg) | 5-[(1S)-1-Hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 91.3 [1], 5248.07 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_955d62cfba50cdc85e83517c26995b66.svg) | 5-[(1S)-1-Hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 337.2 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_955d62cfba50cdc85e83517c26995b66.svg) | 5-[(1S)-1-Hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 2870.0 [1], 15848.93 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_aca6d40a5ddbcbc6b1f90a02fdbfbf43.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 1.19 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_aca6d40a5ddbcbc6b1f90a02fdbfbf43.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 338.84 [1], 341.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_5636bbcabfd704c2d07f0d631e783e6b.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 229.1 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_5636bbcabfd704c2d07f0d631e783e6b.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 239.88 [1], 241.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2da1a77216f5550e06455090d1966f0e.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-(4-methoxynaphthalen-1-yl)propan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 3.98 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2da1a77216f5550e06455090d1966f0e.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-(4-methoxynaphthalen-1-yl)propan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 13.3 [1], 280.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9d843437ffd35eb8a4395f08f45d9caf.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-(4-hydroxyphenyl)butan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 1.44 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9d843437ffd35eb8a4395f08f45d9caf.svg) | 5-[(1R)-1-Hydroxy-2-[[(2R)-1-(4-hydroxyphenyl)butan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 39.1 [1], 1270.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_b8af4b2f8c5741d0b0565b36fb75219a.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-(4-hydroxyphenyl)butan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 17.88 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_b8af4b2f8c5741d0b0565b36fb75219a.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-(4-hydroxyphenyl)butan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 294.0 [1], 5760.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_47e0383c7e95217585fae84227d1171b.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-(4-methoxynaphthalen-1-yl)propan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 4.37 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_47e0383c7e95217585fae84227d1171b.svg) | 5-[(1R)-1-Hydroxy-2-[[(2S)-1-(4-methoxynaphthalen-1-yl)propan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 12.7 [1], 320.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_91c8fea9ea7e2098be7d74c563f8e0ac.svg) | 5-[(1S)-1-Hydroxy-2-[[(2R)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | IC50 | 14.8 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_91c8fea9ea7e2098be7d74c563f8e0ac.svg) | 5-[(1S)-1-Hydroxy-2-[[(2R)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 1778.28 [1], 1784.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9744b3d5a6c31103aec2468ffba68afd.svg) | (6Ar,7R)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-7-ol | IC50 | 1.4 [1], 6.9 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9744b3d5a6c31103aec2468ffba68afd.svg) | (6Ar,7R)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-7-ol | Ki | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_028b726b0bd4cfab1950425844ad1058.svg) | Epinephrine | Ki | 196.0 [1], 360.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_faac9f61879fd14d1ee20cc8818ffd60.svg) | Atenolol | Ki | 9549.93 [1], 10061.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_7ba45ba2f8b56f9250d9067912b4ab0b.svg) | Pindolol | Ki | 0.38 [1], 0.4 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_90fc937ca80a4f307c8f0c3397d5e0f0.svg) | Timolol | Ki | 0.2 [1], 0.21 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_92d5e1170d4cc2a475fe08d4ff8a00c8.svg) | Clenbuterol | Ki | 28.0 [1], 570.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_4d0733f5f19db51e19668cd145fae584.svg) | Levalbuterol | Ki | 3801.89 [1], 4677.35 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2caadd3ec7b2c08ae34435ae889a6a0b.svg) | Darifenacin | Ki | 15.9 [1], 61.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_f8aba9f3e7e7e52b2b80d93116b3a61f.svg) | 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol | IC50 | 0.78 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_f8aba9f3e7e7e52b2b80d93116b3a61f.svg) | 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol | Ki | 0.24 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_1c659afb0f779ac15328cb556219387a.svg) | 4-(3-Hexyl-2-oxoimidazol-1-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]benzenesulfonamide | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_731a68d679edde670e1ece436c6bddf6.svg) | Milveterol | Ki | 3.16 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_35015a3a7e91981c9ac0411f78b352b7.svg) | 1-Hexyl-3-[4-[[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]sulfamoyl]phenyl]urea | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_a43f6005721c3392a7794fcc40d79826.svg) | 4-(3-Hexyl-2-oxoimidazolidin-1-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]benzenesulfonamide | IC50 | 2300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_5e766f3bdb63106fec5bbe801332ade7.svg) | 1-[4-(Diphenylmethyl)piperazin-1-yl]-3-[(3-methyl-1H-indol-4-yl)oxy]propan-2-ol | Ki | 0.3 [1], 0.31 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_ae1260fb5a29888431ee8d07c9f8d636.svg) | 1-(3,5-Diiodo-4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol | Ki | 2.04 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_0376c90955414a1d4ca596b3885abe22.svg) | [3-[(2R)-2-[[(2R)-2-Hydroxy-2-[3-(thiophen-2-ylsulfonylamino)phenyl]ethyl]amino]propyl]-1H-indol-7-yl] methanesulfonate | Ki | 48.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_d3c2de7965cf3b7a3390588074cd1be4.svg) | N-[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-(3-octyl-2-oxoimidazolidin-1-yl)benzenesulfonamide | IC50 | 380.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_b9052dd293ceb39192e43d89b3c1e26c.svg) | CID 16118894 | IC50 | 120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_008c3bf0cb540c72295efc41da8d5c1f.svg) | 1-(4-Methoxyphenoxy)-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propan-2-ol | Ki | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_96c1edb906479ed0ab40654c1dda160b.svg) | N-[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-(3-octyl-2-oxoimidazol-1-yl)benzenesulfonamide | IC50 | 330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9f53aedb90a10d61ff49197d73b8e985.svg) | 1-(Benzo[b]thiophen-2-yl)-N-methylmethanamine | Ki | 43200.0 [1], 373000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9a9877a4c06d68b876831ac2faa1633b.svg) | 7-((R)-2-((1S,2S)-2-(Benzyloxy)cyclopentylamino)-1-hydroxyethyl)-4-hydroxybenzo[d]thiazol-2(3H)-one | Ki | 2.5 [1], 6.1 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_147e629938e079c1fe13f62367c5be8a.svg) | 4-[4-(3,4-Difluorophenyl)-1,3-thiazol-2-yl]-N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]benzenesulfonamide | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_794416aecba597de663cc59fe972d2a5.svg) | 2-(Hydroxymethyl)-4-[2-hydroxy-3-[[1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-yl]amino]propoxy]phenol | IC50 | 2250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_794416aecba597de663cc59fe972d2a5.svg) | 2-(Hydroxymethyl)-4-[2-hydroxy-3-[[1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-yl]amino]propoxy]phenol | Ki | 14.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2ca1f446bcb1a1c82a41373fd545abf1.svg) | 1-[2-(2-Phenylphenoxy)ethylamino]propan-2-ol | Ki | 9.0 [1], 470.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_0c26dd0a89e79637e30c375bfa384b12.svg) | 6-[2-[[2-Hydroxy-3-(1H-indol-4-yloxy)propyl]amino]propoxy]-4H-1,4-benzoxazin-3-one | Ki | 0.63 [1], 1.58 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_cebbf1f5a1701bb37c1c31508542c7c1.svg) | 6-[2-[3-(1H-Indol-4-yloxy)propylamino]ethoxy]-4H-1,4-benzoxazin-3-one | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_2dcfe8c1e236cff43398a310aad9a598.svg) | 4-[(2S)-2-Hydroxy-3-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]propoxy]-1,3-dihydrobenzimidazol-2-one | IC50 | 0.0 [1], 1.3 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_897c90be6f0b54afe7dd9d619ae3bc59.svg) | 7-[(1R)-2-[[(1R,2R)-2-Cyclopentylcyclopentyl]amino]-1-hydroxyethyl]-4-hydroxy-3H-1,3-benzothiazol-2-one | Ki | 0.6 [1], 0.8 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_5d76064ddc2dff8b46597ab1ba156fa1.svg) | (6S)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-6-carboxamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_722c621ffb02e379ed12b3dedfac01e8.svg) | (4R)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-cyclopenta[d][1,3]thiazole-4-carboxamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_c9a0c15c13f721a0f2337b7fea62daca.svg) | 4-(3,5-Diiodo-4-methoxybenzyl)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-amine | IC50 | 56.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_c9a0c15c13f721a0f2337b7fea62daca.svg) | 4-(3,5-Diiodo-4-methoxybenzyl)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-amine | Ki | 426.58 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_cb1d6f674062759737e374ebb7a37e17.svg) | 1H-Indole-3-ethanamine, 5-methoxy-1-methyl- | Ki | 20400.0 [1], 36200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_1ab128e95c5a93c9f00ec10177d1795d.svg) | Ethyl (1S,5R)-3-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]benzoyl]-3-azabicyclo[3.1.0]hexane-6-carboxylate | IC50 | 13400.0 [1], 20000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_6aa6f280e0799bc282e847cf94881886.svg) | N-(1-Benzothiophen-2-ylmethyl)-3-methyloxetan-3-amine | Ki | 1000000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9133e3715ca5d59d5003b22c814ccb7f.svg) | N-[2-(5-Methoxy-1-methylindol-3-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine | Ki | 10400.0 [1], 25000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_010826551bbab40dec26fb74d81b40e3.svg) | N-[[2-Fluoro-5-(trifluoromethoxy)phenyl]methyl]-2-(5-methoxy-1-methylindol-3-yl)ethanamine | Ki | 80400.0 [1], 83800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_9bbb6cadfbebebf685e3c176a6d53ac1.svg) | 1-(2-Methylphenyl)-N-[(4-pyrimidin-2-ylphenyl)methyl]ethanamine | Ki | 4390.0 [1], 268000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_d6d65ecd98f12f747782320a39f65ffb.svg) | 3-(4-Chlorophenyl)-N-[2-(5-methoxy-1-methylindol-3-yl)ethyl]propan-1-amine | Ki | 520.0 [1], 3900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_6ba61061a03464a9d4e5e07d06118d1b.svg) | 2-(Furan-2-yl)-2-[[4-(1,3-thiazol-2-yl)phenyl]methylamino]ethanol | Ki | 95400.0 [1], 1000000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_23577b5056ba57b3b340fa1ba108f9f9.svg) | 4,4,4-Trifluoro-N-[[4-(1,3-thiazol-2-yl)phenyl]methyl]butan-2-amine | Ki | 52300.0 [1], 393000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_eabe61c12b27ba7feca144e5927c3a34.svg) | 5-[(1S)-1-Hydroxy-2-[[(2R)-1-phenylpropan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 22908.68 [1], 23125.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_e449c6752a5c10b34f6743d52505a6a5.svg) | 5-[(1S)-1-Hydroxy-2-[[(2S)-1-phenylpropan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 28624.0 [1], 28840.32 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_19abb1fe2f913f1b4ce1d43a492570a2.svg) | (S)-(+)-5-(1-Hydroxy-2-phenethylaminoethyl)-1,3-benzenediol | Ki | 20417.38 [1], 20562.0 [2] |
![](https://images.aatbio.com/dataset/ic50/beta-2-adrenergic-receptor_bfdd327a082e5d846bf321c187fc8bd7.svg) | 5-[(1S)-1-Hydroxy-2-[[(2S)-1-naphthalen-1-ylpropan-2-yl]amino]ethyl]benzene-1,3-diol | Ki | 2511.89 [1], 2535.0 [2] |